XS Technologies® Microbial Platform For Protein Expression

The biopharmaceuticals market is a rapidly evolving space. To deliver new therapies to patients, novel molecules must be produced quickly and at scale using robust systems and processes. In addition, regulatory compliance is critical to enable migration into the clinical setting and ultimately to the market.

XS Technologies® are the microbial expression systems for today’s therapeutics. Leverage the power of the XS Technologies® microbial platform (including Pichia and E. coli expression systems) in your own lab with a Lonza in Your Lab™ license. Or, leave strain and process development in Lonza’s hands with our microbial CDMO services.